摘要 |
A pharmaceutical composition comprises, in association with a pharmaceutically acceptable carrier, human insulin and human proinsulin in a weight ratio, human insulin to human proinsulin, of from about 1:100 to about 100:1, and which is useful in treating diabetics and in promoting attainment of natural hormonal homeostasis. |